Skip to main content
OpenTrials

Clinical trial condition

Gallbladder Cancer

Explore clinical trials studying Gallbladder Cancer. Study availability and eligibility vary by location and protocol.

82 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Gallbladder Cancer trial results

Completed

Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers

NCT01926236

Conditions
Adenocarcinoma, Ampullary Cancer, Biliary Tract Cancer, +13 more
Locations
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • Bristol Haematology & Oncology Centre Bristol, United Kingdom
  • North Cumbria University Hospitals Carlisle, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
View all 17 locations
View Trial Details
Completed

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

NCT00789958

Conditions
Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +9 more
Locations
  • Regional Medical Center Anniston, Alabama, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • Peninsula Medical Center Burlingame, California, United States
View all 251 locations
View Trial Details
Completed

S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma

NCT00033540

Conditions
Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +9 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
View all 112 locations
View Trial Details
Completed

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

NCT01313377

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +17 more
Locations
  • CHU - Hôpital Nord Amiens, France
  • Centre Paul Papin Angers, France
  • Institut Sainte Catherine Avignon, France
  • Centre hospitalier de la Côte Basque Bayonne, France
View all 37 locations
View Trial Details
Completed

Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

NCT00059865

Conditions
Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +12 more
Locations
  • Cancer Center of Kansas, PA - Chanute Chanute, Kansas, United States
  • Cancer Center of Kansas, PA - Dodge City Dodge City, Kansas, United States
  • Cancer Center of Kansas, PA - El Dorado El Dorado, Kansas, United States
  • Cancer Center of Kansas, PA - Kingman Kingman, Kansas, United States
View all 41 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

NCT00009893

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +17 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
View all 19 locations
View Trial Details

Related conditions